| Literature DB >> 11979003 |
C M Halloran1, P Ghaneh, L Bosonnet, M N Hartley, R Sutton, J P Neoptolemos.
Abstract
Pancreatic cancer is a common cause of cancer death in the developed world. Currently, resection is the only chance of long-term survival. The post-operative mortality in nonspecialist centres often exceeds 20% but is around 6% or less in specialist centres. The overall complication rate even in specialist centres is 18-54%. An analysis of eleven large series of pancreatic resections shows an incidence of common complications of 10.4% for fistula, 9.9% for delayed gastric emptying, 4.8% for bleeding, 4.8% for wound infection and 3.8% for intra-abdominal abscess. The median hospital stay is 13-18 days in different series. The re-operation rate varies from 4 to 9% with a mortality rate of 23 to 67%. Major complications are a significant factor in post-operative mortality, especially if they require re-operation. The use of octreotide or somatostatin to prevent complications is supported by several multicentre, double-blind, randomized controlled trials. The best way to improve outcome is to concentrate pancreatic cancer care in regional specialist centres. Copyright 2002 S. Karger AG, BaselEntities:
Mesh:
Substances:
Year: 2002 PMID: 11979003 DOI: 10.1159/000052029
Source DB: PubMed Journal: Dig Surg ISSN: 0253-4886 Impact factor: 2.588